Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210108985> ?p ?o ?g. }
- W3210108985 abstract "Asthma prevalence has increased considerably over the decades and it is now considered as one of the most common chronic disorders in the world. While the current anti-asthmatic therapies are effective for most asthma patients, there are 5-10% subjects whose disease is not controlled by such agents and they account for about 50% of the asthma-associated healthcare costs. Such patients develop severe asthma (SA), a condition characterized by a dominant Th1/Th17 cytokine response that is accompanied by Type 2 (T2)-low endotype. As JAK (Janus Kinase) signaling is very important for the activation of several cytokine pathways, we examined whether inhibition of JAKs might lessen the clinical and laboratory manifestations of SA. To that end, we employed a recently described murine model that recapitulates the complex immune response identified in the airways of human SA patients. To induce SA, mice were sensitized with house dust mite extract (HDME) and cyclic (c)-di-GMP and then subsequently challenged with HDME and a lower dose of c-di-GMP. In this model, treatment with the JAK inhibitor, Ruxolitinib, significantly ameliorated all the features of SA, including airway hyperresponsiveness and lung inflammation as well as total IgE antibody titers. Thus, these studies highlight JAKs as critical targets for mitigating the hyper-inflammation that occurs in SA and provide the framework for their incorporation into future clinical trials for patients that have severe or difficult-to manage asthma." @default.
- W3210108985 created "2021-11-08" @default.
- W3210108985 creator A5002158147 @default.
- W3210108985 creator A5003464029 @default.
- W3210108985 creator A5043464730 @default.
- W3210108985 creator A5048127745 @default.
- W3210108985 creator A5080366526 @default.
- W3210108985 creator A5089029249 @default.
- W3210108985 date "2021-10-29" @default.
- W3210108985 modified "2023-09-29" @default.
- W3210108985 title "Ruxolitinib Ameliorates Airway Hyperresponsiveness and Lung Inflammation in a Corticosteroid-Resistant Murine Model of Severe Asthma" @default.
- W3210108985 cites W1417342202 @default.
- W3210108985 cites W1488482313 @default.
- W3210108985 cites W1526700155 @default.
- W3210108985 cites W1940020093 @default.
- W3210108985 cites W1965387285 @default.
- W3210108985 cites W1967261754 @default.
- W3210108985 cites W1995648886 @default.
- W3210108985 cites W1996995272 @default.
- W3210108985 cites W2007031153 @default.
- W3210108985 cites W2011754426 @default.
- W3210108985 cites W2014869583 @default.
- W3210108985 cites W2014974499 @default.
- W3210108985 cites W2016951403 @default.
- W3210108985 cites W2017022988 @default.
- W3210108985 cites W2024490058 @default.
- W3210108985 cites W2024704386 @default.
- W3210108985 cites W2024716296 @default.
- W3210108985 cites W2027753595 @default.
- W3210108985 cites W2041112507 @default.
- W3210108985 cites W2041885763 @default.
- W3210108985 cites W2044961935 @default.
- W3210108985 cites W2047128789 @default.
- W3210108985 cites W2050155729 @default.
- W3210108985 cites W2052121459 @default.
- W3210108985 cites W2054425952 @default.
- W3210108985 cites W2063907751 @default.
- W3210108985 cites W2064246691 @default.
- W3210108985 cites W2065801967 @default.
- W3210108985 cites W2067626809 @default.
- W3210108985 cites W2068681515 @default.
- W3210108985 cites W2070098490 @default.
- W3210108985 cites W2076428414 @default.
- W3210108985 cites W2078678444 @default.
- W3210108985 cites W2079145939 @default.
- W3210108985 cites W2082624887 @default.
- W3210108985 cites W2085946223 @default.
- W3210108985 cites W2092836519 @default.
- W3210108985 cites W2110645241 @default.
- W3210108985 cites W2118842534 @default.
- W3210108985 cites W2124566107 @default.
- W3210108985 cites W2125660522 @default.
- W3210108985 cites W2127600861 @default.
- W3210108985 cites W2127854030 @default.
- W3210108985 cites W2128802200 @default.
- W3210108985 cites W2131437805 @default.
- W3210108985 cites W2132173287 @default.
- W3210108985 cites W2140709510 @default.
- W3210108985 cites W2142165321 @default.
- W3210108985 cites W2151734278 @default.
- W3210108985 cites W2159272088 @default.
- W3210108985 cites W2160838704 @default.
- W3210108985 cites W2164262821 @default.
- W3210108985 cites W2169532933 @default.
- W3210108985 cites W2200166704 @default.
- W3210108985 cites W2468702571 @default.
- W3210108985 cites W2539048632 @default.
- W3210108985 cites W2568766196 @default.
- W3210108985 cites W2587946996 @default.
- W3210108985 cites W2593240146 @default.
- W3210108985 cites W2593565645 @default.
- W3210108985 cites W2615513142 @default.
- W3210108985 cites W2616677193 @default.
- W3210108985 cites W2728293354 @default.
- W3210108985 cites W2728759164 @default.
- W3210108985 cites W2730604407 @default.
- W3210108985 cites W2732226050 @default.
- W3210108985 cites W2743335049 @default.
- W3210108985 cites W2760366204 @default.
- W3210108985 cites W2761557216 @default.
- W3210108985 cites W2765851819 @default.
- W3210108985 cites W2810408945 @default.
- W3210108985 cites W2885411864 @default.
- W3210108985 cites W2898586096 @default.
- W3210108985 cites W2901324087 @default.
- W3210108985 cites W2939247829 @default.
- W3210108985 cites W2945283471 @default.
- W3210108985 cites W2980914075 @default.
- W3210108985 cites W2981373208 @default.
- W3210108985 cites W2989422182 @default.
- W3210108985 cites W3009904570 @default.
- W3210108985 cites W3014675989 @default.
- W3210108985 cites W3025075911 @default.
- W3210108985 cites W3025427388 @default.
- W3210108985 cites W3026860418 @default.
- W3210108985 cites W3121891609 @default.
- W3210108985 cites W3131959715 @default.
- W3210108985 cites W3158867971 @default.
- W3210108985 cites W4240832402 @default.
- W3210108985 cites W4250965296 @default.